Unchanged insulin absorption after 4 days' use of subcutaneous indwelling catheters for insulin injections

Diabetes Care

Volumn 20, Issue 4, 1997, Pages 487-490

  Hanas, S Ragnar ^a   Carlsson, Sten ^a   Frid, Anders ^b   Ludvigsson, Johnny ^c  

^a UDDEVALLA HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; IODINE 125; NEUTRAL INSULIN; POTASSIUM IODIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ABSORPTION; FEMALE; HUMAN; INDWELLING CATHETER; INJECTION; INSULIN TREATMENT; MALE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030902097     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.4.487     Document Type: Article

References (13)

1. Hanas R, Ludvigsson J: Experience of pain from insulin injections using syringes, pens and indwelling catheters (Abstract). Horm Res 31:198, 1989
2. Hanas R, Ludvigsson J: Side effects and indwelling times of subcutaneous catheters for insulin injections: a new device for injecting insulin with a minimum of pain in the treatment of insulin-dependent diabetes. Diabetes Res Clin Pract 10:73-83, 1990
3. Long AM, Hughes IA: Indwelling cannula for insulin administration in diabetes mellitus. Arch Dis Child 66:348-349, 1991
4. Hanas R, Ludvigsson J: Metabolic control is not altered when using indwelling catheters for insulin injections. Diabetes Care 17:716-718, 1994
5. Rayman G, Wise PH: An indwelling subcutaneous FEP cannula for intermittent insulin injection: patient experience and effect on diabetic control. Diabet Med 5:592-565, 1988
6. 125I-insulin from an injection site measured with an uncollimated gamma-camera (Abstract). Eur J Nucl Med 21 (Suppl.):S216, 1994
7. Hildebrandt P: Subcutaneous absorption of insulin in insulin-dependent diabetic patients: influence of species, physico-chemical properties of insulin and physiological factors. Dan Med Bull 38:337-346, 1991
8. Olsson PO, Arnqvist H, Asplund J: No pharmacokinetic effect of retaining the infusion site up to four days during continuous subcutaneous insulin infusion therapy. Diabet Med 10:477-480, 1993
9. Liu D, Moberg E, Wredling R, Lins PE, Adamsson U: Insulin absorption is faster when keeping the infusion site in use for three days during continuous subcutaneous insulin infusion. Diabetes Res Clin Pract 12:19-24, 1991
10. Käär ML, Knip M, Mäenpää J: Insulin administration via a subcutaneous catheter. Diabetes Care 16:1412-1413, 1993
11. Knip M, Käär ML, Mäenpää J: No evidence of an accelerated absorption of exogenous insulin after using a subcutaneous catheter for 5 days in children with IDDM (Letter). Diabetes Care 17:627, 1994
12. Kölendorf K: Insulin absorption from subcutis: problems and solutions. Thesis, Copenhagen, Denmark, 1984
13. Lauritzen T: Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy. Dan Med Bull 32:104-118, 1985